Connect with us


Cannabis prescriber Dr Sunny Nayee joins Akanda as medical director

Dr Nayee will focus on improving the level of care provided to medical patients in the UK.



Dr Nayee has been prescribing cannabis since 2019

Chronic pain expert and leading UK medical cannabis prescriber, Dr Sunny Nayee, has joined Akanda to focus on improving patient care.

International medical cannabis company, Akanda, has named chronic pain expert and experienced cannabis prescriber, Dr Sunny Nayee as its new UK medical director. 

The appointment of Dr Nayee builds upon the company’s recent partnership with Cellen – the health tech company behind one of the UK’s first fully-digital pain clinics – in a bid to expand patient access to cannabis medicines.

In his role with Akanda, Dr Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.

Dr Nayee has been prescribing cannabis since 2019, and currently treats in excess of 1,000 patients. 

Dr Sunny Nayee

He holds prizes from the NHS Strategic Health Authority’s innovation committee and Royal College of General Practitioners for work related to patient safety and has published research reviewing the safety and effectiveness of medical cannabis treatment for the treatment of chronic refractory pain. 

He joins Akanda from the Lyphe Group, where he served as medical director.

Read more: Akanda – first UK company listing on NASDAQ with African operations

Dr Nayee commented: “My focus has always been on accurately diagnosing patients then giving them access to the best treatment options available.

“I’m excited to join up with Akanda and Cellen to play a fundamental role in helping to democratise access to medical cannabis for patients in need.”

Dr Nayee will be working closely with Cellen to enable Akanda to better address unmet healthcare needs of patients globally, starting with the UK. 

Akanda recently signed a Memorandum of Understanding with the company, which will see the two work together to optimise medical cannabis supply chain activities across Cellen and Akanda business interests, to increase supply and choice for patients in the UK.

“It is an honour to welcome Dr Nayee to the Akanda team as we build the first seed-to-patient model, serving medical cannabis patients in the UK and Europe,” commented Tej Virk, Akanda’s CEO. 

“Dr. Nayee is a renowned pain treatment expert with direct experience in cannabis therapies. This makes him the ideal face of Akanda for patients. I’m looking forward to having Dr Nayee by our side as we build a patient-oriented supply chain in the UK and eventually other international markets.”

For more industry news visit Cannabis Wealth

Home » Industry » Cannabis prescriber Dr Sunny Nayee joins Akanda as medical director

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister titles, Cannabis Wealth and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2023 PP Intelligence Ltd.